Search

Biopharma needs a new R&D, innovation model

BIOPHARMA NEEDS A NEW R&D, INNOVATION MODEL

Strategic partnerships are one way for biopharmaceutical companies to expand capabilities and offerings and proactively define their...

Bio Roundup: Alzheimer's Puzzle, ESMO Assessed, Drug Prices & More

BIO ROUNDUP: ALZHEIMER'S PUZZLE, ESMO ASSESSED, DRUG PRICES & MORE

In the biotech investment and research communities this week, much of the attention was turned to Europe. Munich, Germany, hosted the...

 
 
 
BIO Investor Forum Explores “Digiceuticals” as a New Class of FDA-Approved Therapeutics

BIO INVESTOR FORUM EXPLORES “DIGICEUTICALS” AS A NEW CLASS OF FDA-APPROVED THERAPEUTICS

Within the past year, the FDA has launched a provider pre-certification program as a pilot to manage the expansion of “digiceuticals”...

 
 
 
2018 BIO Investor Forum Wraps Up

2018 BIO INVESTOR FORUM WRAPS UP

As the stock market continued its volatile swings this week, investors at the BIO Investor Forum -which wrapped up today in San Francisco-seemed...

Bio Roundup: Amarin's Stunner, Lung Cancer News, Data Dumps & More

BIO ROUNDUP: AMARIN'S STUNNER, LUNG CANCER NEWS, DATA DUMPS & MORE

Six years ago, a biotech called Amarin won FDA approval of a prescription fish-oil pill, Vascepa, because it could lower triglycerides,...

 
 
 
Principia Sets IPO Terms as It Eyes Late-Stage Studies for Lead Drug

PRINCIPIA SETS IPO TERMS AS IT EYES LATE-STAGE STUDIES FOR LEAD DRUG

Principia Biopharma plans to sell 4.6 million shares priced between $15 and $17 apiece when the rare disease drug developer makes its...

ADMINISTRATIVE ASSISTANT - SAN DIEGO BIOPHARMA - SAN DIEGO, CA

Ensures document text and graphics adhere to corporate and organization guidelines and standards. Uses appropriate tools for required...

 
 
 
Bio Roundup: EpiPen Shortage, Bluebird's Bet, Biotech IPOs & More

BIO ROUNDUP: EPIPEN SHORTAGE, BLUEBIRD'S BET, BIOTECH IPOS & MORE

It's back-to-school season and that means it's time to load up on school supplies. For many students and schools, one crucial item...

Sierra Oncology Acquires Gilead's Stalled Myelofibrosis Drug

SIERRA ONCOLOGY ACQUIRES GILEAD'S STALLED MYELOFIBROSIS DRUG

An experimental myelofibrosis drug that fell short of expectations for Gilead Sciences is getting another shot under Sierra Oncology....

 
 
 

SENIOR VALIDATION SPECIALIST - 1092 - TANVEX BIOPHARMA USA,INC - SAN DIEGO, CA

Candidate uses data collection systems for temperature mapping controlled storage units and autoclave qualifications, performs data...

 
 
 
Bio Roundup: An Alzheimer's Head-Scratcher, OUTBio, GSK & Gilead Shakeups  

BIO ROUNDUP: AN ALZHEIMER'S HEAD-SCRATCHER, OUTBIO, GSK & GILEAD SHAKEUPS  

The devil is in the details, and key clinical trial results made that abundantly clear this week. Eisai and partner Biogen released...

 
 
 

AXOVANT LICENSES BENITEC MUSCULAR DYSTROPHY DRUG, CONTINUING PIVOT TOWARD GENE THERAPIES

Axovant has picked up global rights to Benitec Biopharma's gene therapy against oculopharyngeal muscular dystrophy. The gene therapy,...

I-MAB CLOSES ONE OF CHINA'S BIGGEST-EVER BIOTECH FUNDRAISINGS

China's I-Mab Biopharma just raised a massive $220 million in a third-round fundraising that once again reveals the growing strength...

 
 
 
Bio Roundup: Big Bucks For Calico, Data Dumps & The IPO Wave Rolls On

BIO ROUNDUP: BIG BUCKS FOR CALICO, DATA DUMPS & THE IPO WAVE ROLLS ON

If you're running a privately held biotech, the time to go public is now. Clinical data already in hand or not, biotechs have charged...

Don't Be Boston 2.0, And Photos From “Bringing Back the Expats”

DON'T BE BOSTON 2.0, AND PHOTOS FROM “BRINGING BACK THE EXPATS”

View the Slideshow Be your own biotech cluster, not a Boston redux. Accelerate the momentum that's already begun, don't let it fizzle....

 
 
 

LABORATORY TECHNICIAN - VETSTEM BIOPHARMA - POWAY, CA

This role could be an excellent starting point of your career to gain industry experience within a biotechnology corporation...From...

Wednesday's Fireside Chat: Financing Innovation & Doing Social Good

WEDNESDAY'S FIRESIDE CHAT: FINANCING INNOVATION & DOING SOCIAL GOOD

Massachusetts' biopharma industry is arguably the strongest in the world. That is due in large part to the successful cooperation of...